| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 78350-50-2 | 3-氨基呋咱-4-羧酸; 4-氨基-1,2,5-恶二唑-3-羧酸 | 3-Aminofurazan-4-carboxylic acid; 4-Aminofurazan-3-carboxylic acid; 5-Aminofurazane-4-carboxylic acid; 4-Amino-1,2,5-oxadiazole-3-carboxylic acid |  | C3H3N3O3 | 详情 | 供应商 |
| 90002-06-5 | 2-[5-(氯甲基)-1,2,4-恶二唑-3-基]吡啶 | 2-[5-(Chloromethyl)-1,2,4-oxadiazol-3-yl]pyridine; 5-(Chloromethyl)-3-(pyridin-2-yl)-1,2,4-oxadiazole |  | C8H6ClN3O | 详情 | 供应商 |
| 147403-03-0 | 阿齐沙坦; 2-乙氧基-1-[[2'-(4,5-二氢-5-氧代-1,2,4-恶二唑-3-基)联苯-4-基]甲基]苯并咪唑-7-羧酸 | Azilsartan; 2-Ethoxy-1-[[2'-(4,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid |  | C25H20N4O5 | 详情 | 供应商 |
| 370103-73-4 | (1,2,4-恶二唑-3-基)甲胺 | (1,2,4-Oxadiazol-3-yl)methanamine; 1,2,4-Oxadiazole-3-methanamine,monohydrochloride (9CI); (1,2,4-Oxadiazol-3-ylmethyl)amine hydrochloride |  | C3H5N3O | 详情 | 供应商 |
| 588730-16-9 | N,4-二甲基-1,2,5-恶二唑-3-甲胺 | N,4-Dimethyl-1,2,5-oxadiazole-3-methanamine; 3-(Methylaminomethyl)-4-methylfurazan |  | C5H9N3O | 详情 | 供应商 |
| 775304-57-9 | 3-[5-(2-氟苯基)-1,2,4-恶二唑-3-基]苯甲酸 | 3-[5-(2-Fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid; Ataluren |  | C15H9FN2O3 | 详情 | 供应商 |
| 852180-60-0 | 4-(5-甲基-1,2,4-恶二唑-3-基)苯甲醛 | 4-(5-Methyl-1,2,4-oxadiazol-3-yl)benzaldehyde; 4-(5-METHYL-1,2,4-OXADIAZOL-3-YL)BENZALDEHYDE |  | C10H8N2O2 | 详情 | 供应商 |
| 932742-86-4 | 4-(5-甲基-1,2,4-恶二唑-3-基)苄胺 | 4-(5-Methyl-1,2,4-oxadiazol-3-yl)benzylamine |  | C10H11N3O | 详情 | 供应商 |
| 10185-69-0 | 3-(5-甲基-1,2,4-恶二唑-3-基)苯胺 | 3-(5-METHYL-1,2,4-OXADIAZOL-3-YL)ANILINE |  | C9H9N3O | 详情 | 供应商 |
| 863031-21-4 | 1-[[2'-(2,5-二氢-5-氧代-1,2,4-恶二唑-3-基)[1,1'-联苯]-4-基]甲基]-2-乙氧基-1H-苯并咪唑-7-羧酸 (5-甲基 | 1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazol; 1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester; Azilsartan medoxomil; TAK 491 |  | C24H20N4O3 | 详情 | 供应商 |
| 937174-76-0 | 4-[2-(4-氨基-1,2,5-恶二唑-3-基)-1-乙基-7-[(3S)-3-哌啶基甲氧基]-1H-咪唑并[4,5-C]吡啶-4-基]-2-甲基-3-? | 4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4; 4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-3-butyn-2-ol; GSK 690693; (R)-4-(2-(4-AMINO-1,2,5-OXADIAZOL-3-YL)-1-ETHYL-7-(PIPERIDIN-3-YLMETHOXY)-1H-IMI |  | C21H27N7O3 | 详情 | 供应商 |
| 914471-09-3 | 4-氨基-N-(3-氯-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒; 4-氨基-N-(3-氯-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒 | indoleaMine-2,3-dioxygenase inhibitor INCB024360; INCB 024360; INCB024360; INCB-024360; INCB-24360; indoleaMine-2,3-dioxygenase inhibitor INCB024360; INCB024360/INCB-024360; 4-Amino-N-(3-chloro-4-fluorophenyl)-N'-hydroxy-1,2,5-oxadiazole-3-carboximidamide | 无 | C9H7ClFN5O2 | 详情 | 供应商 |
